s6y
Company name or ticker
Search
Orexigen Therapeutics, Inc.
3
JORN DEBORA: Initial statement of beneficial ownership of securities
Filed
Tuesday, May 24, 2016
Period
May 20, 2016
Accession number
0001209191-16-122853
Documents
FORM 3 SUBMISSION
3
POA DOCUMENT
EX-24.3_657010
On sec.gov
Filing index
All files
Complete submission text
SGML header